P3 Health Partners (NASDAQ:PIII) Releases Earnings Results, Beats Estimates By $1.26 EPS

P3 Health Partners (NASDAQ:PIII) issued its earnings results on Monday. The company reported ($0.63) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.89) by $1.26, FiscalAI reports. The company had revenue of $386.38 million during the quarter, compared to analyst estimates of $377.80 million.

P3 Health Partners Stock Up 10.8%

Shares of PIII traded up $1.25 during trading hours on Monday, reaching $12.83. The company’s stock had a trading volume of 277,176 shares, compared to its average volume of 569,285. The firm has a market cap of $92.95 million, a price-to-earnings ratio of -0.33 and a beta of 1.63. P3 Health Partners has a 1-year low of $1.52 and a 1-year high of $16.89. The company has a 50 day moving average of $10.98 and a two-hundred day moving average of $6.33.

Analysts Set New Price Targets

PIII has been the subject of a number of recent analyst reports. Wall Street Zen upgraded P3 Health Partners to a “hold” rating in a research report on Saturday, July 4th. Lake Street Capital reiterated a “buy” rating and issued a $14.00 target price (up from $4.00) on shares of P3 Health Partners in a report on Friday, May 15th. TD Cowen restated a “hold” rating and set a $14.00 price target (up from $3.00) on shares of P3 Health Partners in a report on Friday, May 22nd. UBS Group set a $14.00 price target on shares of P3 Health Partners in a research report on Friday, May 15th. Finally, Weiss Ratings raised shares of P3 Health Partners from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, May 28th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, P3 Health Partners has a consensus rating of “Hold” and an average target price of $14.00.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.